DEFINING THE REGULATION OF GD2 EXPRESSION TO ENHANCE IMMUNOTHERAPY FOR NEUROBLASTOMA

$1,535,725FY2022Defense Health AgencyDOD

Dana-Farber Cancer Institute, Inc.

Investigators

DEFINING THE REGULATION OF GD2 EXPRESSION TO ENHANCE IMMUNOTHERAPY FOR NEUROBLASTOMA · GrantIndex